U.S. market Closed. Opens in 1 day 10 hours 27 minutes

ORMP | Oramed Pharmaceuticals Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-08-312020-08-312019-08-312018-08-312017-08-312016-08-312015-08-312014-08-312013-08-312012-08-312011-08-312010-08-312009-08-312008-08-312007-08-312006-08-312005-08-312004-08-312003-08-31
Revenue1.34M2.70M2.70M2.71M2.70M2.45M2.46M641.00KN/AN/AN/A184.25K197.41KN/AN/AN/AN/AN/AN/AN/AN/A
Cost of RevenueN/AN/AN/A90.00K90.00K86.00K187.00K490.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit1.34M2.70M2.70M2.62M2.61M2.36M2.27M151.00KN/AN/AN/A184.25K197.41KN/AN/AN/AN/AN/AN/AN/AN/A
Operating Expenses17.11M43.30M26.93M14.47M17.24M16.06M13.04M10.16M7.38M5.91M4.30M2.88M2.44M2.97M2.78M2.68M3.13M412.88K44.81K720.00K50.00K
Selling, General & Admin8.14M15.66M5.94M4.23M3.72M4.08M2.76M2.45M2.60M2.63M2.03M1.20M1.28M1.51M1.26M1.50M918.00K215.13K44.81K280.00K50.00K
Research & Development8.97M27.64M20.99M10.23M13.52M11.98M10.28M7.71M4.78M3.28M2.27M1.68M1.16M1.46M1.52M1.18M2.21M197.75KN/AN/A10.00K
Other Operating ExpensesN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A440.00K-10.00K
Operating Income-15.77M-40.60M-24.22M-11.76M-14.63M-13.53M-10.77M-10.01M-7.38M-5.91M-4.30M2.88M-2.44M-2.97M-2.78M-2.68M-3.13M-412.88K-44.81K-720.00K-50.00K
Other Expenses / Income20.86M2.93M893.00K-438.00K-450.00K-30.00K-10.00K-17.00K-3.00K214.00K-164.72K-184.25K835.59K10.15K21.05K5.29M-104.00K-1.69K-973.00N/AN/A
Before Tax Income5.09M-37.66M-22.99M-11.51M-14.05M-12.73M-10.08M-9.63M-7.23M-5.69M-4.44M-3.25M-1.59M-2.96M-2.76M2.61M-3.24M-414.58K-45.78K-720.00K-50.00K
Income Tax ExpensesN/A100.00K-2.88M192.00K300.00K-800.00K400.00K1.33M-1.00K4.00K-205.06K90.22K-23.98K14.97K-2.60K162.16K3.24M414.58K45.78KN/AN/A
Net Income5.53M-37.76M-22.24M-11.51M-14.36M-12.73M-10.48M-10.96M-7.23M-5.70M-4.23M-3.34M-1.56M-2.98M-2.76M-2.77M-3.24M-414.58K-45.78K-720.00K-50.00K
Interest Expenses3.58MN/AN/AN/AN/AN/AN/AN/AN/A11.00K313.45K199.12K18.78K14.54K17.55K10.28K-3.24M3.68K-44.81KN/AN/A
Basic Shares Outstanding40.32M39.00M28.47M20.53M17.45M14.88M13.31M12.62M10.82M9.24M7.21M5.88M5.42M4.78M4.72M4.05M3.52M2.78M1.54M2.54M2.90M
Diluted Shares Outstanding40.57M39.00M28.47M20.53M17.45M14.88M13.31M12.62M10.82M9.24M7.21M5.88M5.42M4.78M4.72M4.05M3.52M2.78M1.54M2.54M2.90M
EBITDA-15.57M-36.98M-25.04M-11.31M-14.17M-13.49M-10.76M-9.99M-7.38M-5.67M-4.13M-2.86M-2.37M-2.92M-2.72M-2.66M-3.02M-412.88K-44.81K-720.00K-50.00K
EBITDA Margin-1,162.16%-1,367.96%-926.34%-417.42%-524.34%-550.88%-437.95%-1,558.35%0.00%0.00%0.00%-1,550.11%-1,202.43%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT9.11M-37.66M-25.12M-11.32M-14.05M-13.53M-10.08M-9.63M-7.23M-5.68M-4.12M-3.06M-1.57M-2.95M-2.75M-2.60M-3.24M3.68K-44.81K-720.00K-50.00K
EBIT Margin679.48%-1,393.41%-929.19%-417.68%-519.98%-552.35%-410.42%-1,502.18%0.00%0.00%0.00%-1,658.11%-793.49%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-08-312020-08-312019-08-312018-08-312017-08-312016-08-312015-08-312014-08-312013-08-312012-08-312011-08-312010-08-312009-08-312008-08-312007-08-312006-08-312005-08-312004-08-312003-08-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙